Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
10.62
+0.27 (2.61%)
At close: Sep 18, 2026, 4:00 PM EDT
10.63
+0.01 (0.09%)
After-hours: Sep 18, 2026, 7:30 PM EDT
Immunic Employees
Immunic had 100 employees as of June 30, 2026. The number of employees increased by 10 or 11.11% compared to the same quarter last year.
Employees
100
Change
10
Growth
11.11%
Revenue / Employee
n/a
Profits / Employee
-$1,115,660
Market Cap
144.90M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 100 | 10 | 11.11% |
| Mar 31, 2026 | 95 | 5 | 5.56% |
| Dec 31, 2025 | 92 | 1 | 1.10% |
| Sep 30, 2025 | 90 | 5 | 5.88% |
| Jun 30, 2025 | 90 | 5 | 5.88% |
| Mar 31, 2025 | 90 | 10 | 12.50% |
| Dec 31, 2024 | 91 | 14 | 18.18% |
| Sep 30, 2024 | 85 | 5 | 6.25% |
| Jun 30, 2024 | 85 | 10 | 13.33% |
| Mar 31, 2024 | 80 | 7 | 9.59% |
| Dec 31, 2023 | 77 | 11 | 16.67% |
| Sep 30, 2023 | 80 | 15 | 23.08% |
| Jun 30, 2023 | 75 | 15 | 25.00% |
| Mar 31, 2023 | 73 | 18 | 32.73% |
| Dec 31, 2022 | 66 | 11 | 20.00% |
| Sep 30, 2022 | 65 | 13 | 25.00% |
| Jun 30, 2022 | 60 | 15 | 33.33% |
| Mar 31, 2022 | 55 | 15 | 37.50% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Codexis | 146 |
| Molecular Partners AG | 134 |
| Caribou Biosciences | 97 |
| Tenaya Therapeutics | 70 |
| Neumora Therapeutics | 63 |
| Corbus Pharmaceuticals Holdings | 36 |
| TuHURA Biosciences | 22 |
| Unicycive Therapeutics | 22 |
IMUX News
- 11 days ago - Immunic Transcript: R&D Day 2026 - Transcripts
- 11 days ago - Immunic Slides: FY 2026 - Filings
- 16 days ago - Immunic Slides: Corporate presentation - Filings
- 17 days ago - Immunic Slides: Investor presentation - Filings
- 18 days ago - Immunic to Host Virtual Relapsing Multiple Sclerosis R&D Day on September 9, 2026 - PRNewsWire
- 19 days ago - Immunic price target raised to $29 from $19 at Roth Capital - TheFly
- 19 days ago - Immunic appoints Chitrang Dave as chief data, digital officer - TheFly
- 19 days ago - Immunic Appoints Chitrang Davé as Chief Data and Digital Officer - PRNewsWire